Top Markets
#1 Black Phoenix Black Phoenix +335.94%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +66.31%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.65%
#6 OpenEden OpenEden +34.31%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.88%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +18.65%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Classificação em ações #40710
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Preço da ação
$0.065
Última sincronização: 2025-01-10
Valor de mercado
$94.10K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar TFF Pharmaceuticals, Inc. (TFFP)

Categoria

Healthcare
Histórico de preços das ações de TFF Pharmaceuticals, Inc. (TFFP)
Preço de fecho mais alto: $0.07 em 2025-01-01

Preço de fecho mais baixo: $126.10 em 2019-10-01
Histórico de preços das ações da TFF Pharmaceuticals, Inc. de 2019 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2025 -56.50%
2024 -98.17%
2023 -67.74%
2022 -87.63%
2021 -45.27%
2020 191.03%
2019 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $518.36 30.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $859.40 32.91%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE